Integrating behavioral economics and behavioral genetics: delayed reward discounting as an endophenotype for addictive disorders.
Delay discounting is a useful, changeable addiction marker, not a life sentence.
01Research in Context
What this study did
MacKillop (2013) looked at years of animal and human data. He asked if steep delay discounting could be a stable, heritable marker for addiction risk.
The paper is a narrative review, not an experiment. It pulls together genetics, brain chemistry, and discounting curves.
What they found
The review says delay discounting shows promise as an "endophenotype" — a measurable trait that sits between genes and behavior.
Yet the evidence is still patchy. More work is needed before we use discounting as a stand-alone risk screener.
How this fits with other research
Green et al. (2019) seems to disagree. They show many people with drug problems actually discount money less steeply than controls. The clash fades when you see James focused on trait-like curves while Green highlights context and reward type.
Rung et al. (2019) build forward. They show brief behavioral drills can flatten discounting, proving the trait is not locked.
Miller et al. (2024) extend again. Their 2-minute "willingness-to-wait" task predicts drinking severity better than the old discounting quiz, giving clinicians a faster tool.
Why it matters
For BCBAs in addiction programs, this means delay discounting is worth tracking, but don’t treat one steep curve as destiny. Pair it with short new probes like willingness-to-wait and keep testing behavioral fixes that teach clients to wait for larger, later rewards.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add a two-minute willingness-to-wait trial to your intake battery and note if clients quit early for smaller rewards.
02At a glance
03Original abstract
Delayed reward discounting is a behavioral economic index of impulsivity, referring to how much an individual devalues a reward based on its delay in time. As a behavioral process that varies considerably across individuals, delay discounting has been studied extensively as a model for self-control, both in the general population and in clinical samples. There is growing interest in genetic influences on discounting and, in particular, the prospect of discounting as an endophenotype for addictive disorders (i.e., a heritable mechanism partially responsible for conferring genetic risk). This review assembles and critiques the evidence supporting this hypothesis. Via numerous cross-sectional studies and a small number of longitudinal studies, there is considerable evidence that impulsive discounting is associated with addictive behavior and appears to play an etiological role. Moreover, there is increasing evidence from diverse methodologies that impulsive delay discounting is temporally stable, heritable, and that elevated levels are present in nonaffected family members. These findings suggest that impulsive discounting meets the criteria for being considered an endophenotype. In addition, recent findings suggest that genetic variation related to dopamine neurotransmission is significantly associated with variability in discounting preferences. A significant caveat, however, is that the literature is modest in some domains and, in others, not all the findings have been supportive or consistent. In addition, important methodological considerations are necessary in future studies. Taken together, although not definitive, there is accumulating support for the hypothesis of impulsive discounting as an endophenotype for addictive behavior and a need for further systematic investigation.
Journal of the experimental analysis of behavior, 2013 · doi:10.1002/jeab.4